Durso Timothy August sold $4.7M of MANE
Durso Timothy August (Chief Technical Officer) sold 43,500 shares of Veradermics, Inc (MANE) at an average of $107.82 ($106.71–$111.28, $4.69M total) across 5 trades on 2026-08-17 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
This is a primary disclosure of insider selling by the CTO, executed across five trades at $106.71 to $111.28 per share, totaling about $4.69M, with a stated 10b5-1 plan.
Market read
Traders may monitor for sentiment effects from insider selling, but there is no accompanying fundamental catalyst in the text.
What to watch
The filing does not state whether the insider retained meaningful exposure beyond the post-sale holdings, nor does it provide context on total compensation or prior sale cadence.
Background
The article is an SEC Form 4 insider transaction disclosure for Veradermics, Inc (MANE).
Ticker impact
Form 4 shows MANE CTO Durso Timothy August sold 43,500 shares in open-market trades for about $4.69M under a 10b5-1 plan.
Likely limited near-term impact; any reaction would be sentiment-driven rather than fundamental.
The filing is a primary-source insider transaction with a stated 10b5-1 plan, and it does not include new company fundamentals, guidance, or regulatory/contract events.
Market effects
No clear sector read-through because the disclosure is company-specific and lacks operational or regulatory details.
None indicated.
None indicated.
Counterpoint
The sale may reflect routine liquidity needs under a scheduled 10b5-1 plan, so it may not signal deteriorating fundamentals.
Key entities
- issuerVeradermics, Inc
Company whose insider transaction is disclosed on SEC Form 4.
- insiderDurso Timothy August
Chief Technical Officer who sold 43,500 shares in open-market trades.
- trading mechanism10b5-1 plan
Pre-arranged plan cited as Yes, which typically reduces interpretive weight of the sale.
